Statins suppress interleukin‐6‐induced monocyte chemo‐attractant protein‐1 by inhibiting Janus kinase/signal transducers and activators of transcription pathways in human vascular endothelial cells
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Background and purpose: The mechanisms of anti‐inflammatory actions of statins, 3‐hydroxy‐3‐methylglutaryl CoA (HMG‐CoA) reductase inhibitors, remain unclear. We investigated the effects of statins on interleukin (IL)‐6‐induced monocyte chemo‐attractant protein (MCP)‐1 expression and monocyte chemotaxis. Experimental approach: Cultures of human aortic endothelial cells (HAECs) were stimulated with IL‐6 in the absence and presence of statins. Gene expression and protein secretion of MCP‐1, phosphorylation of Janus kinase (JAK) and the signal transducers and activators of transcription (STAT) pathway, and human monocyte migration were examined. Key results: IL‐6 plus its soluble receptor sIL‐6R (IL‐6/sIL‐6R) promoted THP‐1 monocyte migration, and increased gene expression and protein secretion of MCP‐1, more than IL‐6 alone or sIL‐6R alone. Various statins inhibited IL‐6/sIL‐6R‐promoted monocyte migration and MCP‐1 expression in HAECs. Co‐incubation of mevalonate and geranylgeranyl pyrophosphate, but not farnesyl pyrophosphate, reversed the inhibitory effects of statins on MCP‐1 expression. Geranylgeranyl transferase inhibitor, but not farnesyl transferase inhibitor, suppressed IL‐6/sIL‐6R‐stimulated MCP‐1 expression. IL‐6/sIL‐6R rapidly phosphorylated JAK1, JAK2, TYK2, STAT1 and STAT3, which were inhibited by statins. Transfection of STAT3 small interfering RNA (siRNA), but not STAT1 siRNA, attenuated the ability of IL‐6/sIL‐6R to enhance THP‐1 monocyte migration. In addition, statins blocked IL‐6/sIL‐6R‐induced translocation of STAT3 to the nucleus. Conclusions and implications: Statins suppressed IL‐6/sIL‐6R‐induced monocyte chemotaxis and MCP‐1 expression in HAECs by inhibiting JAK/STAT signalling cascades, explaining why statins have anti‐inflammatory properties beyond cholesterol reduction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394 · cited 2×
“These isoprenoids are necessary for the post-translational isoprenylation of various proteins that are involved in cell signalling pathways (Goldstein and Brown, 1990; Casey, 1995).”
BackgroundInterleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
HEINRICH, P. C., BEHRMANN, I., MÜLLER-NEWEN, G., SCHAPER, F., & GRAEVE, L. (1998) · Biochemical Journal · doi:10.1042/bj3340297 · Cited by 2,130 · cited 3×
“IL-6 is a multifunctional cytokine that acts on a variety of target cells to regulate their growth and differentiation (Heinrich et al., 1998).”
BackgroundBoring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965 · cited 1×
“In contrast, inhibition of MCP-1/CCR2 pathway prevents initiation and development of atherosclerotic lesions (Boring et al., 1998; Gosling et al., 1999).”
BackgroundGuide to receptors and channels (GRAC), 5th edition
Alexander, S., Mathie, A., & Peters, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01649_1.x · Cited by 1,947
Cited by
Pleiotropic Effects of Statins on the Cardiovascular System
Oesterle, A., Laufs, U., & Liao, J. K. (2017) · Circulation Research · doi:10.1161/circresaha.116.308537 · Cited by 1,247
Zhang, C., Li, Y., Wu, Y., Wang, L., Wang, X., & Du, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.419788 · Cited by 279
“(34) reported that statins inhibited IL-6-induced CCL2 expression of human aortic endothelial cells via suppressing STAT3 phosphorylation, STAT3 siRNA transfection inhibited THP-1 monocyte migration enhanced by IL-6/soluble IL-6R.”
Diamantis, E., Kyriakos, G., Quiles-Sanchez, L. V., Farmaki, P., & Troupis, T. (2017) · Current Cardiology Reviews · doi:10.2174/1573403x13666170426104611 · Cited by 259
Innate and Adaptive Inflammation as a Therapeutic Target in Vascular Disease
Tousoulis, D., Psarros, C., Demosthenous, M., Patel, R., Antoniades, C., & Stefanadis, C. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.01.054 · Cited by 187
“A recent study showed that statins prevented the induction of monocyte chemoattractant protein (MCP)-1 and monocyte chemotaxis by suppressing IL-6 on human aortic endothelial cells (58).”
BackgroundPinho-Gomes, A. C., Reilly, S., Brandes, R. P., & Casadei, B. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5542 · Cited by 94
Metadata
- Authors
- Jougasaki, M., Ichiki, T., Takenoshita, Y., & Setoguchi, M.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2010-03
- Volume
- 159
- Issue
- 6
- Pages
- 1294-1303
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1709568328
- Cited by
- 98
- References
- 4
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Statins suppress interleukin‐6‐induced monocyte chemo‐attractant protein‐1 by inhibiting Janus kinase/signal transducers and activators of transcription pathways in human vascular endothelial cells. https://app.cochat.ai/papers/10.1111/j.1476-5381.2009.00612.x
- The paper
- Jougasaki, M., Ichiki, T., Takenoshita, Y., & Setoguchi, M. (2010). Statins suppress interleukin‐6‐induced monocyte chemo‐attractant protein‐1 by inhibiting Janus kinase/signal transducers and activators of transcription pathways in human vascular endothelial cells. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2009.00612.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.